Intranasal insulin therapy: the clinical
โ
J. Hilsted; S. Madsbad; A. Hvidberg; M. H. Rasmussen; T. Krarup; H. Ipsen; B. Ha
๐
Article
๐
1995
๐
Springer
๐
English
โ 514 KB
To evaluate metabolic control and safety parameters (hypoglycaemia frequency and nasal mucosa physiology), 31 insulin-dependent diabetic patients were treated with intranasal insulin at mealtimes for i month and with subcutaneous fast-acting insulin at meals for another month in an open, crossover r